These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 38375981)

  • 1. Biomarkers of transfusion transmitted occult hepatitis B virus infection: Where are we and what next?
    Fu MX; Simmonds P; Andersson M; Harvala H
    Rev Med Virol; 2024 Mar; 34(2):e2525. PubMed ID: 38375981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prevalence of viral hepatitis B markers among blood donors in the Republic of Guinea].
    Boumbaly S; Balde TAL; Semenov AV; Ostankova YV; Serikova EN; Naidenova EV; Valutite DE; Shchemelev AN; Zueva EB; Esaulenko EV; Totolian AA
    Vopr Virusol; 2022 Mar; 67(1):59-68. PubMed ID: 35293189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrasensitive PCR system for HBV DNA detection: Risk stratification for occult hepatitis B virus infection in English blood donors.
    Fu MX; Simmonds P; Andreani J; Baklan H; Webster M; Asadi R; Golubchik T; Breuer J; Ijaz S; Ushiro-Lumb I; Brailsford S; Irving WL; Andersson M; Harvala H
    J Med Virol; 2023 Oct; 95(10):e29144. PubMed ID: 37796091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitation of HBV cccDNA in anti-HBc-positive liver donors by droplet digital PCR: A new tool to detect occult infection.
    Caviglia GP; Abate ML; Tandoi F; Ciancio A; Amoroso A; Salizzoni M; Saracco GM; Rizzetto M; Romagnoli R; Smedile A
    J Hepatol; 2018 Aug; 69(2):301-307. PubMed ID: 29621551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Occult hepatitis B virus infection: implications in transfusion.
    Allain JP
    Vox Sang; 2004 Feb; 86(2):83-91. PubMed ID: 15023176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A method for estimating the residual risk of transfusion-transmitted HBV infection associated with occult hepatitis B virus infection in a donor population without universal anti-HBc screening.
    Seed CR; Kiely P
    Vox Sang; 2013 Nov; 105(4):290-8. PubMed ID: 23802710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood donor screening in the Netherlands: Universal anti-HBc screening in combination with HBV nucleic acid amplification testing may allow discontinuation of hepatitis B virus antigen testing.
    van de Laar TJ; Hogema BM; Molenaar-de Backer MW; Marijt-van der Kreek T; Zaaijer HL
    Transfusion; 2021 Jul; 61(7):2116-2124. PubMed ID: 33899233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Residual risk of transfusion-transmitted hepatitis B virus (TT-HBV) infection by NAT-screened blood components: A review of observed versus modeled infectivity from donors with window period and occult HBV infections.
    Lelie N; Busch M; Kleinman S
    Transfusion; 2021 Nov; 61(11):3190-3201. PubMed ID: 34590320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Occult Hepatitis B Virus Infection in Nigerian Blood Donors and Hepatitis B Virus Transmission Risks.
    Oluyinka OO; Tong HV; Bui Tien S; Fagbami AH; Adekanle O; Ojurongbe O; Bock CT; Kremsner PG; Velavan TP
    PLoS One; 2015; 10(7):e0131912. PubMed ID: 26148052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular and Serological Characterization of Hepatitis B Virus (HBV)-Positive Samples with Very Low or Undetectable Levels of HBV Surface Antigen.
    Kuhns MC; Holzmayer V; Anderson M; McNamara AL; Sauleda S; Mbanya D; Duong PT; Dung NTT; Cloherty GA
    Viruses; 2021 Oct; 13(10):. PubMed ID: 34696483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-hepatits B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practice.
    Bhatti FA; Ullah Z; Salamat N; Ayub M; Ghani E
    Transfusion; 2007 Jan; 47(1):74-9. PubMed ID: 17207233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Occult hepatitis B virus infection among blood donors from the Brazilian Amazon: implications for transfusion policy.
    Moresco MN; Virgolino Hde A; de Morais MP; da Motta-Passos I; Gomes-Gouvêa MS; de Assis LM; Aguiar KR; Lombardi SC; Malheiro A; Cavalheiro Nde P; Levi JE; Torres KL
    Vox Sang; 2014 Jul; 107(1):19-25. PubMed ID: 24697276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B virus nucleic acid amplification testing of Australian blood donors highlights the complexity of confirming occult hepatitis B virus infection.
    Kiely P; Margaritis AR; Seed CR; Yang H;
    Transfusion; 2014 Aug; 54(8):2084-91. PubMed ID: 24650170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Occult hepatitis B infection and transfusion-transmission risk.
    Candotti D; Boizeau L; Laperche S
    Transfus Clin Biol; 2017 Sep; 24(3):189-195. PubMed ID: 28673499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Occult hepatitis B virus infection.
    Allain JP
    Transfus Clin Biol; 2004 Feb; 11(1):18-25. PubMed ID: 14980545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infectivity of blood products from donors with occult hepatitis B virus infection.
    Allain JP; Mihaljevic I; Gonzalez-Fraile MI; Gubbe K; Holm-Harritshøj L; Garcia JM; Brojer E; Erikstrup C; Saniewski M; Wernish L; Bianco L; Ullum H; Candotti D; Lelie N; Gerlich WH; Chudy M
    Transfusion; 2013 Jul; 53(7):1405-15. PubMed ID: 23362802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New strategies for blood donor screening for hepatitis B virus: nucleic acid testing versus immunoassay methods.
    Kuhns MC; Busch MP
    Mol Diagn Ther; 2006; 10(2):77-91. PubMed ID: 16669606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Refining the risk estimate for transfusion-transmission of occult hepatitis B virus.
    Seed CR; Kiely P; Hoad VC; Keller AJ
    Vox Sang; 2017 Jan; 112(1):3-8. PubMed ID: 27564651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stochastic model for estimating the risk of transfusion-transmitted hepatitis B in Vietnam.
    Viet L; Husebekk A; Husum H; Skjerve E
    Transfus Med; 2013 Dec; 23(6):423-31. PubMed ID: 23786316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transfusion-transmitted HBV infection with isolated anti-HBs-positive blood.
    Satake M; Yamagishi N; Tanaka A; Goto N; Sakamoto T; Yanagino Y; Furuta RA; Matsubayashi K
    Transfusion; 2023 Jun; 63(6):1250-1254. PubMed ID: 37129363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.